You are here
Angiochem is well funded with top-tier investors committed to the success of the company.
BDC provides small and medium-sized businesses with flexible financing, affordable consulting services and venture capital. BDC supports the needs of entrepreneurs at every stage of growth.
The VIMAC Milestone Medica Fund (VMM) is a life sciences venture capital fund providing equity financing to entrepreneurial companies.
Valeo Management L.P. was formed to commercialize the results of research carried out by its member universities, including the Université du Québec network and Concordia University.
Angiochem has also received support from the Industrial Research Assistance Program (IRAP), the Rx&D tax credit of Canada and Quebec province, and from a group of angel investors in Quebec City.